MmTron Inc. (20240293684). mmWave Array and Implanted Susceptors for Hyperthermia-Based Anti-Cancer Treatments simplified abstract
Contents
mmWave Array and Implanted Susceptors for Hyperthermia-Based Anti-Cancer Treatments
Organization Name
Inventor(s)
Seyed A Tabatabaei of Half Moon Bay CA (US)
mmWave Array and Implanted Susceptors for Hyperthermia-Based Anti-Cancer Treatments - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240293684 titled 'mmWave Array and Implanted Susceptors for Hyperthermia-Based Anti-Cancer Treatments
The abstract of this patent application describes methods and systems for hyperthermia-based anti-cancer treatments. One system includes an array of millimeter wave amplifier integrated circuits, medical grade implantable susceptors, and a beam steering controller to direct the output energy of the amplifier circuits into the susceptors.
- The system utilizes millimeter wave technology for anti-cancer treatments.
- It includes medical grade implantable susceptors for targeted treatment.
- A beam steering controller is used to direct the energy output into the susceptors.
- The technology aims to deliver hyperthermia-based treatments for cancer therapy.
- The system offers a novel approach to cancer treatment using hyperthermia.
Potential Applications: - Cancer therapy - Hyperthermia-based treatments - Medical device technology
Problems Solved: - Targeted delivery of hyperthermia for cancer treatment - Improved efficacy of anti-cancer treatments
Benefits: - Targeted and effective cancer therapy - Minimized side effects compared to traditional treatments
Commercial Applications: Title: Hyperthermia-Based Anti-Cancer Treatment System This technology could be used in medical facilities for cancer therapy, potentially offering a more targeted and efficient treatment option for patients. The market implications include improved outcomes and reduced side effects for cancer patients undergoing treatment.
Questions about Hyperthermia-Based Anti-Cancer Treatment System: 1. How does hyperthermia-based treatment differ from traditional cancer therapies? Hyperthermia-based treatment uses heat to target and destroy cancer cells, offering a potentially more targeted approach compared to traditional treatments like chemotherapy or radiation therapy.
2. What are the potential advantages of using medical grade implantable susceptors in cancer therapy? Medical grade implantable susceptors allow for targeted delivery of energy to specific areas, potentially increasing the effectiveness of the treatment while minimizing damage to surrounding healthy tissue.
Original Abstract Submitted
methods and systems for hyperthermia-based anti-cancer treatments are disclosed herein. one disclosed system for hyperthermia-based anti-cancer treatments includes an array of millimeter wave amplifier integrated circuits having an output energy, one or more medical grade implantable susceptors, and a beam steering controller for the array of millimeter wave amplifier integrated circuits that is configured to steer the output energy of the array of millimeter wave amplifier integrated circuits into the one or more medical grade implantable susceptors.
